Typically our diabetes patients have changes in vision and they totally ignore them. They blame it on age, environment, old glasses and any other excuse. We as medical professionals don’t stress the possible changes enough because we are more focused on things like neuropathy and kidney failure. This means that …
Read More »Daily Archives: Jun 28, 2016
Dr. A. Paul Chous Part 3, What’s New in the Treatment of Diabetic Eye Disease
In part 3 of this Exclusive Interview, Dr. Chous gives a brief tour of what's on the horizon in treating diabetic eye disease.
Read More »Pharmacologic Management of Type 2 Diabetes Part 3
In this week's Homerun Slides, the Canadian Diabetes Association lists insulin action and examples of insulin initiation and titration regimens in people with type 2.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #30: Insulin Gene Expression and Biosynthesis Part 6 of 6
Regulation of proinsulin conversion: PC2 and PC1/3 are Ca2+-dependent enzyme activities with an acidic pH 5 – 5.5 optimum. Fortunately, the beta granule contains an intraorganellar environment of 1 – 10 mM free Ca2+ and acidic pH 5.5, which ideally suits the requirements for optimal PC2, PC1/3 and CP-H activities within this organelle.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.